Arcadia Biosciences, Inc. (RKDA) is a publicly traded Basic Materials sector company. As of June 13, 2026, RKDA trades at $0.96 with a market cap of $2.20M and a P/E ratio of -0.18. RKDA moved -4.67% today. Year to date, RKDA is -52.75%; over the trailing twelve months it is -78.89%. Its 52-week range spans $0.80 to $10.31. Rallies surfaces RKDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for RKDA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.96 |
| Market Cap | $2.20M |
| P/E Ratio | -0.18 |
| EPS | $-5.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.31 |
| 52-Week Low | $0.80 |
| Volume | 2.58M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.76M |
| Net Income | $-9.28M |
| Gross Margin | 34.51% |
RKDA analyst coverage data. Average price target: $0.00.